| Literature DB >> 35294873 |
Song-Hua Hu1, Xia-Di He1, Ji Nie1, Jun-Li Hou2, Jiang Wu3, Xiao-Yan Liu4, Yun Wei1, Hui-Ru Tang5, Wen-Xing Sun1, Shu-Xian Zhou1, Yi-Yuan Yuan1, Yan-Peng An5, Guo-Quan Yan5, Yan Lin1, Peng-Cheng Lin6, Jean J Zhao7, Ming-Liang Ye8, Jian-Yuan Zhao9, Wei Xu10, Shi-Min Zhao11.
Abstract
Protein fatty acylation regulates numerous cell signaling pathways. Polyunsaturated fatty acids (PUFAs) exert a plethora of physiological effects, including cell signaling regulation, with underlying mechanisms to be fully understood. Herein, we report that docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) regulate PI3K-AKT signaling by modifying PDK1 and AKT2. DHA-administered mice exhibit altered phosphorylation of proteins in signaling pathways. Methylene bridge-containing DHA/EPA acylate δ1 carbon of tryptophan 448/543 in PDK1 and tryptophan 414 in AKT2 via free radical pathway, recruit both the proteins to the cytoplasmic membrane, and activate PI3K signaling and glucose uptake in a tryptophan acylation-dependent but insulin-independent manner in cultured cells and in mice. DHA/EPA deplete cytosolic PDK1 and AKT2 and induce insulin resistance. Akt2 knockout in mice abrogates DHA/EPA-induced PI3K-AKT signaling. Our results identify PUFA's methylene bridge tryptophan acylation, a protein fatty acylation that regulates cell signaling and may underlie multifaceted effects of methylene-bridge-containing PUFAs.Entities:
Keywords: Akt signaling; DHA/EPA; fatty acylation
Mesh:
Substances:
Year: 2022 PMID: 35294873 PMCID: PMC9396916 DOI: 10.1016/j.celrep.2022.110509
Source DB: PubMed Journal: Cell Rep Impact factor: 9.995